Llwytho...
Biomarkers for Immune Checkpoint Inhibitor-Mediated Tumor Response and Adverse Events
In the last decade, inhibitors targeting immune checkpoint molecules such as cytotoxic T-lymphocyte antigen 4 (CTLA-4), programmed cell death 1 (PD-1), and programmed cell death-ligand 1 (PD-L1) brought about a major paradigm shift in cancer treatment. These immune checkpoint inhibitors (ICIs) impro...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Front Med (Lausanne) |
|---|---|
| Prif Awdur: | |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Frontiers Media S.A.
2019
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6549005/ https://ncbi.nlm.nih.gov/pubmed/31192215 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmed.2019.00119 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|